• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    2/14/23 7:45:07 AM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Saba Capital Management, L.P.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

    Data Knights Acquisition Corp

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    237699103

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [_]  Rule 13d-1(b)

     [X]  Rule 13d-1(c)

     [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13G/A

    CUSIP No.           237699103


    1 Names of Reporting Persons

    Saba Capital Management, L.P.
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    PN; IA
           

    The percentages used herein are calculated based upon 12,085,275 shares of common stock outstanding as of November 18, 2022, as disclosed in the company's 10-Q filed November 18, 2022.

    Page 2 of 7


    SCHEDULE 13G/A

    CUSIP No.           237699103


    1 Names of Reporting Persons

    Boaz R. Weinstein
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    United States
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    IN
           

    The percentages used herein are calculated based upon 12,085,275 shares of common stock outstanding as of November 18, 2022, as disclosed in the company's 10-Q filed November 18, 2022.

    Page 3 of 7


    CUSIP No.           237699103


    1 Names of Reporting Persons

    Saba Capital Management GP, LLC
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    OO
           

    The percentages used herein are calculated based upon 12,085,275 shares of common stock outstanding as of November 18, 2022, as disclosed in the company's 10-Q filed November 18, 2022.

    Page 4 of 7


    Item 1.

    (a) Name of Issuer: Data Knights Acquisition Corp

    (b) Address of Issuer's Principal Executive Offices: Trident Court, 1 Oakcroft Road, Chessington, Surrey, United Kingdom, KT9 1BD

    Item 2.

    (a) Name of Person Filing: Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"), Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"), and Mr. Boaz R. Weinstein (together, the "Reporting Persons").  The Reporting Persons have entered into a Joint Filing Agreement, dated May 17, 2021, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.  The filing of this statement should not be construed as an admission that any of the forgoing persons or the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

    (b) Address of Principal Business Office or, if None, Residence:  The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.

    (c) Citizenship: Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.

    (d) Title and Class of Securities: Common stock, $0.0001 Par Value (the "Common Stock").

    (e) CUSIP No.: 237699103

    Item 3.  If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    Page 5 of 7


    (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4. Ownership

    (a) Amount Beneficially Owned:    The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

    Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.  N/A

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

    Item 8. Identification and classification of members of the group. N/A

    Item 9. Notice of Dissolution of Group.  N/A

    Item 10. Certifications.

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Page 6 of 7


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  February 14, 2023

    /s/ Signature  Michael D'Angelo

    Name: Michael D'Angelo

    Title: Chief Compliance Officer

    Boaz R. Weinstein

    By: Michael D'Angelo

    Title: Attorney-in-fact***

    *** Pursuant to a Power of Attorney dated as of November 16, 2015

    Page 7 of 7


    Get the next $DKDCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    See more
    • OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

      ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

      5/23/23 4:05:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 4:18:48 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 2:08:21 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

      4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

      8/21/23 6:18:49 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

      ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

      11/9/23 4:15:00 PM ET
      $DKDCA
      $ONMD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

      OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

      11/7/23 2:00:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

      MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

      10/12/23 4:45:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    SEC Filings

    See more
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - OneMedNet Corp (0001849380) (Filer)

      2/9/24 4:15:31 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form S-1 filed by Data Knights Acquisition Corp.

      S-1 - OneMedNet Corp (0001849380) (Filer)

      12/18/23 8:29:14 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - OneMedNet Corp (0001849380) (Filer)

      11/22/23 5:30:12 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/14/24 6:03:43 AM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/5/24 1:55:23 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed by Data Knights Acquisition Corp.

      SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

      4/11/23 12:00:45 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care